Laman Utama1099 • HKG
Sinopharm Group Co Ltd
$20.25
27 Sep, 4:08:28 PTG GMT+8 · HKD · HKG · Penafian
SahamSekuriti tersenarai HK
Tutup sebelumnya
$18.78
Julat hari
$18.86 - $20.55
Julat tahun
$16.02 - $23.00
Permodalan pasaran
63.19B HKD
Bilangan Purata
7.61J
Nisbah P/E
6.60
Hasil dividen
4.72%
Pertukaran utama
HKG
Berita pasaran
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
(CNY)Jun 2024Perubahan T/T
Hasil
-122.51B-0.93%
Perbelanjaan pengendalian
-6.47B-5.44%
Pendapatan bersih
-419.63J30.73%
Margin untung bersih
0.34-32.00%
Pendapatan bagi setiap syer
EBITDA
-2.33B20.26%
Kadar cukai berkesan
26.07%
Jumlah aset
Jumlah liabiliti
(CNY)Jun 2024Perubahan T/T
Pelaburan tunai dan jangka pendek
8.62B-74.94%
Jumlah aset
33.55B-91.97%
Jumlah liabiliti
15.61B-94.87%
Jumlah ekuiti
17.94B
Syer tertunggak
3.12B
Harga kepada buku
3.63
Pulangan pada aset
-2.64%
Pulangan pada modal
-5.30%
Perubahan bersih dalam tunai
(CNY)Jun 2024Perubahan T/T
Pendapatan bersih
-419.63J30.73%
Tunai daripada operasi
46.42B14.53%
Tunai daripada pelaburan
-362.06J22.79%
Tunai daripada pembiayaan
-23.30B-6.05%
Perubahan bersih dalam tunai
22.75B25.76%
Aliran tunai bebas
103.16B370.65%
Perihal
Sinopharm Group Co., Ltd. is a Chinese pharmaceutical company. The parent company of Sinopharm Group was Sinopharm Industrial Investment, a 51–49 joint venture of state-owned enterprise China National Pharmaceutical Group and civilian-run enterprise Fosun Pharmaceutical. Its H shares were listed on the Hong Kong Stock Exchange in 2009, with its IPO price of HK$16 per share. Sinopharm Group's subsidiary Sinopharm CNMC and Sinopharm Accord served as the A share counterpart of the company. However, the A share of Sinopharm Group itself was unlisted. Sinopharm Group was ranked 829th in 2016 Forbes Global 2000 list. Wikipedia
Diasaskan
2003
Tapak web
Pekerja
113,635
Cari
Kosongkan carian
Tutup carian
Apl Google
Menu utama